, Volume 92, Issue 5, pp 711-713
Date: 25 Nov 2012

Splenectomy followed by administration of rituximab is useful to treat a patient with hairy cell leukemia-variant

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access